Predicting heart muscle scarring in patients with mitral valve prolapse
Official title: Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse: the SCIMITAR Trial
Run by Centro Cardiologico Monzino · NCT06341166 · Data updated 2026-11-12
This study is trying to find out if a new scoring system can help identify patients with mitral valve prolapse who are at risk for heart muscle scarring and related problems using heart imaging.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Centro Cardiologico Monzino Academic / other |
| Locations | 1 site (Milan, Milan) |
| Status | Recruiting |
| Started | June 19, 2023 |
| Main results expected | October 19, 2026 |
| Study ends | October 19, 2026 |
| Registry record updated | September 21, 2026 |
| Trial ID | NCT06341166 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older with an echocardiographic diagnosis of mitral valve prolapse.
✕Probably not a fit
Patients under 18 years old or those with other significant heart conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter observational study aims to develop a scoring model to predict myocardial fibrosis in patients diagnosed with mitral valve prolapse (MVP) using cardiac magnetic resonance imaging. It will analyze both prospective and retrospective data to identify specific features that may increase the risk of ventricular arrhythmias or sudden cardiac death in these patients. The study seeks to clarify which patients with MVP should undergo cardiac magnetic resonance to detect potential myocardial fibrosis, which is currently uncertain in routine clinical practice.
Why it matters
Potential benefit: If successful, this study could lead to improved risk stratification and management of patients with mitral valve prolapse.
How similar studies have gone: Other studies have explored similar predictive models in cardiac conditions, but this specific approach to mitral valve prolapse and myocardial fibrosis is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age ≥ 18 years * Echocardiographic diagnosis of mitral valve prolaspe, defined as a systolic displacement of one or both mitral leaflets ≥ 2 mm above the plane of the mitral valve annulus in long-axis views Exclusion Criteria: * age\< 18 years * coexistence of other cardiomyopathies or other ≥ moderate valve diseases * scarce acoustic transthoracic echocardiographic window * usual contraindications for cardiac magnetic resonance
Where it's running
-
Centro Cardiologico Monzino
Milan, Milan, Italy Recruiting
Study contacts
- Study coordinator: Gianluca Pontone, MD
- Email: gianluca.pontone@cardiologicomonzino.it
- Phone: 0258002574
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting high-risk arrhythmic events in people with arrhythmic mitral valve prolapse
This study tests a risk model to see which patients with arrhythmic mitral valve prolapse might need an ICD.
-
AI and 3D ultrasound mapping of mitral valve prolapse shape and function.
This project tests an automated AI system that uses intraoperative 3D transesophageal ultrasound to map mitral valve anatomy and create patient-specific biomechanical models for adults having surgery for degenerative mitral valve prolapse.
-
Korea VHD Echo Study: Real-World Practice of Aortic, Mitral, and Tricuspid Valves
This study looks at how valvular heart disease is managed in Korea by reviewing echocardiograms and medical records from multiple centers to see patterns in disease progression and treatment.
-
Patient-centered decision-making for mitral valve prolapse treatment
This study is trying to understand what patients with mitral valve prolapse and their doctors think about choosing between two treatment options, surgery or a less invasive procedure, to help improve how they make decisions together.
-
Impact of mitral valve surgery on ventricular arrhythmias
This study is testing how mitral valve surgery helps people with mitral valve prolapse and arrhythmias by looking at their heart health before and after the operation.
-
Observational registry for patients treated with the NeoChord Artificial Chordae System
This study is looking at how well the NeoChord Artificial Chordae System works for people with degenerative mitral valve disease over five years, without needing any extra procedures beyond regular treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.